Elutia (ELUT) Liabilities and Shareholders Equity (2019 - 2026)
Elutia recorded quarterly Liabilities and Shareholders Equity of $55.2 million in Q1 2026, down 11.45% quarter-over-quarter from $62.4 million in Q4 2025, and up 40.49% year-over-year from $39.3 million in Q1 2025.
Elutia's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $55.2 million for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 40.49% year-over-year to $55.2 million; the TTM figure through Mar 2026 stood at $180.8 million (up 9.1% YoY), while the FY2025 annual figure was $62.4 million, up 72.59% from the prior year.
- Liabilities and Shareholders Equity came in at $55.2 million for Q1 2026 at Elutia, down from $62.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $68.8 million in Q4 2022 to a low of $29.4 million in Q3 2025.
- A 5-year average of $49.1 million and a median of $52.3 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity sank 41.68% in 2024 and soared 72.59% in 2025, its largest moves.
- Elutia's Liabilities and Shareholders Equity stood at $68.8 million in 2022, then plunged by 36.92% to $43.4 million in 2023, then dropped by 16.81% to $36.1 million in 2024, then jumped by 72.59% to $62.4 million in 2025, then dropped by 11.45% to $55.2 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $55.2 million, $62.4 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 55.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.21 Mn |
| Dec 31, 2025 | 62.35 Mn |
| Sep 30, 2025 | 29.41 Mn |
| Jun 30, 2025 | 33.85 Mn |
| Mar 31, 2025 | 39.30 Mn |
| Dec 31, 2024 | 36.13 Mn |
| Sep 30, 2024 | 48.41 Mn |
| Jun 30, 2024 | 41.90 Mn |
| Mar 31, 2024 | 35.36 Mn |
| Dec 31, 2023 | 43.43 Mn |
| Sep 30, 2023 | 54.58 Mn |
| Jun 30, 2023 | 52.33 Mn |
| Mar 31, 2023 | 60.63 Mn |
| Dec 31, 2022 | 68.84 Mn |
| Sep 30, 2022 | 61.02 Mn |
| Jun 30, 2022 | 52.85 Mn |
| Mar 31, 2022 | 59.93 Mn |
| Dec 31, 2021 | 67.17 Mn |
| Sep 30, 2021 | 59.90 Mn |
| Jun 30, 2021 | 69.70 Mn |
| Mar 31, 2021 | 74.21 Mn |
| Dec 31, 2020 | 82.81 Mn |
| Sep 30, 2020 | 46.14 Mn |
| Dec 31, 2019 | 44.77 Mn |